Novavax vaccine 96% effective against original coronavirus, 86% vs British variant in UK trial
Novavax vaccine 96% effective against original coronavirus, 86% vs British variant in UK trial
Friday, 13:02, 12/03/2021
VOV5
(VOVWORLD) -Novavax’s COVID-19 vaccine was 96% effective in preventing cases caused by the original version of the coronavirus in a late-stage trial conducted in the United Kingdom, the company said on Thursday, moving it a step closer to regulatory approval.
(Photo: Reuters)
The vaccine was also about 86% effective in protecting against the more contagious virus variant first discovered and now prevalent in the UK.
It was about 90% effective overall, combining data from people infected with both versions of the coronavirus.
If authorized, it would follow three COVID-19 vaccines previously approved for use in Britain from Pfizer and partner BioNTech, Moderna and the AstraZeneca shot developed with Oxford University.
(Photo: Reuters)
